drugset / Trial / NCT03974932
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Phase 3b, open-label single-arm study in which all subjects receive HTX-011 as part of a scheduled non-opioid MMA regimen.
Timeline
- Start
- 2019-06-05
- Primary completion
- 2020-12-07
- Completion
- 2021-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | — | — |
| Subject | Celecoxib | Other / unclassified | — | — |
| Subject | HTX-011 | Unknown | — | — |
| Background | Acetaminophen | Small molecule | — | — |
| Background | Ibuprofen | Small molecule | — | — |
Indications
No indication recorded.